GGrantIndex
Sort

4,870 grants matching glp 1

A novel monobody-drug conjugate to treat mutant Ras multiple myeloma

$399,877
Craig Patrick Ramirez · Tezcat Laboratories Llc · R41 · FY2020 · CA

IND-enabling studies of KTX-1161, a novel NRF2 activator for corneal endothelial disease

$399,865
Keith W Ward · Kuria Therapeutics, Inc · R44 · FY2025 · EY

PLA2G2D Antibodies for Cancer Immunotherapy

$399,618
Li-Fen Lee · Apeximmune Therapeutics Inc. · R43 · FY2023 · CA

Borrelia burgdorferi tick phase genes and Lyme disease pathogenesis

$399,583
Ira S. Schwartz · New York Medical College · R01 · FY2011 · AI

BSL-3 Practices Core

$399,567
Farhang Alem · George Mason University · UC7 · FY2023 · AI

14-3-3-zeta regulation of islet health

$399,545
Bethany Paige Cummings · University Of California At Davis · R01 · FY2024 · DK

14-3-3-zeta regulation of islet health

$399,545
Bethany Paige Cummings · University Of California At Davis · R01 · FY2025 · DK

In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma

$399,441
Hamid Ghandehari · Theratarget · R42 · FY2018 · CA

Decipher the Function of C2cd4a in Metabolism

$399,271
Taiyi Diana Kuo · University Of California At Davis · R01 · FY2023 · DK

Pathophysiology of Type 2 Diabetes in Youth

$399,144
Sonia Caprio · Yale University · R01 · FY2006 · HD

Stem cell versus meiotic fate decision in C. elegans

$399,075
Tim B. Schedl · Washington University · R01 · FY2020 · GM

Stem cell versus meiotic fate decision in C. elegans

$399,075
Tim B. Schedl · Washington University · R01 · FY2021 · GM

Stem cell versus meiotic fate decision in C. elegans

$399,075
Tim B. Schedl · Washington University · R01 · FY2023 · GM

Stem cell versus meiotic fate decision in C. elegans

$399,075
Tim B. Schedl · Washington University · R01 · FY2022 · GM

Advancing cancer therapy: Developing antibody blockade targeting a novel immune checkpoint, LAIR1/CD305

$398,997
Jianping Huang · Immunogenik, Inc. · R41 · FY2025 · CA

GLP-1 Effects in Water and Salt Intake

$398,750
Derek Daniels · State University Of New York At Buffalo · R01 · FY2017 · DK

GLP-1 Effects in Water and Salt Intake

$398,750
Derek Daniels · State University Of New York At Buffalo · R01 · FY2018 · DK

GLP-1 Effects in Water and Salt Intake

$398,750
Derek Daniels · State University Of New York At Buffalo · R01 · FY2019 · DK

GLP-1 Effects in Water and Salt Intake

$398,750
Derek Daniels · State University Of New York At Buffalo · R01 · FY2016 · DK

Durable Muscle-Prosthetic Bond for Artificial Tendons

$398,531
Natalia Juncosa-Melvin · Cardioenergetics, Inc. · R44 · FY2008 · AR

Novel Glucagon Modulators and the Closed Loop System

$398,497
Rubina A Heptulla · Albert Einstein College Of Medicine · R01 · FY2012 · DK

Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer

$398,404
John Parkinson · Thetis Pharmaceuticals, Llc · R44 · FY2023 · CA

AI Platform to Discover Therapeutics for Substance Use Disorders

$397,829
Dale Adam Lauver · Callentis Consulting Group Llc · R41 · FY2025 · DA

Appetite Hormones in Binge Eating Disorder

$397,591
Allan Geliebter · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2009 · DK

GLP-1R signaling in allergic inflammation

$397,523
Ray Stokes Peebles · Vanderbilt University Medical Center · R01 · FY2020 · AI